Albuterol

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Albuterol is a short-acting adrenergic beta-agonist, widely used in the immediate treatment of symptomatic asthma and other respiratory diseases. It is a "racemic mixture with a 1:1 ratio of the r-isomer, levalbuterol, and s-albuterol, with the chemical name 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol. [1]

While most often administered through the respiratory tract using a metered dose inhaler or nebulizer, it also can be given orally.

Uses

Approved indications for the inhaled form include:[2]

Off-label uses include: hyperkalemia, familial hyperkalemic periodic paralysis, and respiratory distress in neonates.

Drug comparisons

While it is considered short-acting, its duration of action is longer isoproterenol, is less likely to cause cardiac effects, and as at least as effective as a bronchodilator. [3]

References

  1. Anonymous (2024), Albuterol (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. "Albuterol Inh[aled]", Medscape Drug Information
  3. "Monograph: Albuterol", Medscape Drug Information